Open AccessAvacopan for the Treatment of ANCA-Associated Vasculitis
Author(s) -
David Jayne,
Peter A. Merkel,
Thomas J. Schall,
Pirow Bekker
Publication year - 2021
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa2023386
Subject(s) - vasculitis , anca associated vasculitis , anti neutrophil cytoplasmic antibody , medicine , antibody , immunology , dermatology , disease
The C5a receptor inhibitor avacopan is being studied for the treatment of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom